These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 4881887)
1. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. Wood CD; Graybiel A Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887 [No Abstract] [Full Text] [Related]
2. Effect of drugs in altering susceptibility to motion sickness in aerobatics and the slow rotation room. Deane FR; Wood CD; Graybiel A Aerosp Med; 1967 Aug; 38(8):842-5. PubMed ID: 6049246 [No Abstract] [Full Text] [Related]
3. Motion-sickness medications for aircrew: impact on psychomotor performance. Paul MA; MacLellan M; Gray G Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400 [TBL] [Abstract][Full Text] [Related]
4. Antimotion sickness and antiemetic drugs. Wood CD Drugs; 1979 Jun; 17(6):471-9. PubMed ID: 467277 [No Abstract] [Full Text] [Related]
5. Motion sickness and its prevention by drugs. Brand JJ Curr Med Drugs; 1967 Aug; 7(12):17-26. PubMed ID: 6064966 [No Abstract] [Full Text] [Related]
6. [New drugs for nausea and vomiting. A clinical and physiological study]. Pestel M Presse Med (1893); 1969 May; 77(25):921-3. PubMed ID: 4389499 [No Abstract] [Full Text] [Related]
7. Evaluation of antimotion sickness drug side effects on performance. Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169 [TBL] [Abstract][Full Text] [Related]
8. Effect of drugs on after-nystagmus induced by lateral vestibular nucleus stimulation. Yules RB; Gault FP Arch Otolaryngol; 1967 Mar; 85(3):278-82. PubMed ID: 4381233 [No Abstract] [Full Text] [Related]
9. Evaluation of a new antinauseant drug for the prevention of motion sickness. Graybiel A; Knepton J Aviat Space Environ Med; 1977 Sep; 48(9):867-71. PubMed ID: 334151 [No Abstract] [Full Text] [Related]
10. Treatment of severe motion sickness with antimotion sickness drug injections. Graybiel A; Lackner JR Aviat Space Environ Med; 1987 Aug; 58(8):773-6. PubMed ID: 3632537 [TBL] [Abstract][Full Text] [Related]
11. Human assay of antimotion sickness drugs. Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039 [TBL] [Abstract][Full Text] [Related]
13. A comparison of effectiveness of some antimotion sickness drugs using recommended and larger than recommended doses as tested in the slow rotation room. NSAM-945. Wood CD; Graybiel A; Kennedy RS Res Rep U S Nav Sch Aviat Med; 1965 Jul; ():1-9. PubMed ID: 5322559 [No Abstract] [Full Text] [Related]
14. Prevention of experimental motion sickness by scopolamine absorbed through the skin. Graybiel A; Knepton J; Shaw J Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234 [TBL] [Abstract][Full Text] [Related]
15. Comparison of marezine and dramamine in preventing symptoms of motion sickness. Weinstein SE; Stern RM Aviat Space Environ Med; 1997 Oct; 68(10):890-4. PubMed ID: 9327113 [TBL] [Abstract][Full Text] [Related]
16. Side effects of some antimotion sickness drugs as measured by psychomotor test and questionnaires. Kennedy RE; Wood CD; Graybiel A; McDonough RB Aerosp Med; 1966 Apr; 37(4):408-11. PubMed ID: 5954449 [No Abstract] [Full Text] [Related]